Recent Advances in Pharmacological Treatments of Adult Dermatomyositis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Advances in Pharmacological Treatments of Adult Dermatomyositis
Authors
Keywords
Clinically amyopathic dermatomyositis, Classic dermatomyositis, Interstitial lung disease, Therapeutics, Treatment algorithms
Journal
Current Rheumatology Reports
Volume 21, Issue 10, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-31
DOI
10.1007/s11926-019-0850-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody–positive Polymyositis/dermatomyositis–associated Interstitial Lung Disease: A Propensity Score–matched Analysis
- (2019) Hironao Hozumi et al. JOURNAL OF RHEUMATOLOGY
- Systemic Treatment for Clinically Amyopathic Dermatomyositis at 4 Tertiary Care Centers
- (2019) Joanie Pinard et al. JAMA Dermatology
- Abatacept for the treatment of rheumatoid arthritis
- (2019) Manuel Pombo-Suarez et al. Expert Review of Clinical Immunology
- Intravenous immunoglobulin is an effective treatment for refractory cutaneous dermatomyositis
- (2018) F. Galimberti et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- 503 Tofacitinib for recalcitrant cutaneous dermatomyositis
- (2018) A. Alsarheed et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Anti-melanoma differentiation–associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features
- (2018) Drew J.B. Kurtzman et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis
- (2018) Adam Schiffenbauer et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- A case of clinically amyopathic dermatomyositis that developed during anti-TNF-α therapy for rheumatoid arthritis
- (2018) Miki Takata et al. ALLERGOLOGY INTERNATIONAL
- Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis
- (2018) Thomas Barba et al. AUTOIMMUNITY REVIEWS
- Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists
- (2018) Hitoshi Kohsaka et al. JOURNAL OF DERMATOLOGY
- Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib
- (2018) Siamak Moghadam-Kia et al. RHEUMATOLOGY
- Recent developments on treatment strategies and the prognosis of dermatomyositis: a review
- (2017) Verena Isak et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Cannabinoid Reduces Inflammatory Cytokines, Tumor Necrosis Factor-α, and Type I Interferons in Dermatomyositis In Vitro
- (2017) Elizabeth S. Robinson et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
- (2017) Peter Saunders et al. Trials
- Treatment of clinically amyopathic dermatomyositis in adults: a systematic review
- (2016) J. Callander et al. BRITISH JOURNAL OF DERMATOLOGY
- Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis
- (2016) Ken-ichi Ueno et al. International Journal of Rheumatic Diseases
- Guidelines on dermatomyositis - excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology
- (2016) Cord Sunderkötter et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial
- (2016) Nicolino Ruperto et al. LANCET
- Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab
- (2016) Rohit Aggarwal et al. RHEUMATOLOGY
- Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis
- (2016) Siamak Moghadam-Kia et al. ARTHRITIS CARE & RESEARCH
- Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis
- (2016) Drew J. B. Kurtzman et al. JAMA Dermatology
- Corticosteroid Monotherapy Is Usually Insufficient Treatment for Idiopathic Inflammatory Myopathy
- (2015) Tanisha Mathur et al. AMERICAN JOURNAL OF THERAPEUTICS
- The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review
- (2015) Yongpeng Ge et al. CLINICAL RHEUMATOLOGY
- Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis
- (2015) Yusuke Yokoyama et al. Modern Rheumatology
- Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients
- (2015) Nicholas E. Johnson et al. NEUROMUSCULAR DISORDERS
- Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease
- (2015) Dong Jin Go et al. RHEUMATOLOGY INTERNATIONAL
- Remission of Recalcitrant Dermatomyositis Treated with Ruxolitinib
- (2014) Thorsten Hornung et al. NEW ENGLAND JOURNAL OF MEDICINE
- The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis
- (2014) Takashi Kurita et al. RHEUMATOLOGY
- A case of overlap syndrome successfully treated with tocilizumab: a hopeful treatment strategy for refractory dermatomyositis?
- (2014) M. Kondo et al. RHEUMATOLOGY
- Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up
- (2013) Mei Zong et al. ANNALS OF THE RHEUMATIC DISEASES
- A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
- (2013) Brandon W Higgs et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease
- (2013) T. Bounfour et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Suppression of soluble T cell-associated proteins by an anti-interferon- monoclonal antibody in adult patients with dermatomyositis or polymyositis
- (2013) X. Guo et al. RHEUMATOLOGY
- Predictors of Clinical Improvement in Rituximab-Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis
- (2013) Rohit Aggarwal et al. Arthritis & Rheumatology
- Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
- (2012) David Wong et al. PLoS One
- Pathogenesis of Dermatomyositis: Role of Cytokines and Interferon
- (2011) Lily Kao et al. Current Rheumatology Reports
- Tumor Necrosis Factor Inhibitor–Associated Dermatomyositis
- (2010) Rachel Klein et al. ARCHIVES OF DERMATOLOGY
- Incidence of Dermatomyositis and Clinically Amyopathic Dermatomyositis
- (2010) Margo J. Bendewald et al. ARCHIVES OF DERMATOLOGY
- Mycophenolate mofetil for interstitial lung disease in dermatomyositis
- (2010) Pamela A. Morganroth et al. ARTHRITIS CARE & RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search